Translational Autoinflammatory Disease (TADS) is a clinical research site located in Bethesda, Maryland, United States 20892.
Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.
Translational Autoinflammatory Disease (TADS) has participated in 1 clinical trials.
Therapeutic areas: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE), Juvenile Dermatomyositis (JDM), Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI).
Sponsors: Eli Lilly and Company.
Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Translational Autoinflammatory Disease (TADS) has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Translational Autoinflammatory Disease (TADS) has 1 clinical trials on record. Their work covers Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE), Juvenile Dermatomyositis (JDM), Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI).
Translational Autoinflammatory Disease (TADS) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.